<?xml version='1.0' encoding='utf-8'?>
<document id="27684210"><sentence text="In vitro assessment of the roles of drug transporters in the disposition and drug-drug interaction potential of olaparib."><entity charOffset="112-120" id="DDI-PubMed.27684210.s1.e0" text="olaparib" /></sentence><sentence text="1" /><sentence text=" In vitro assessments were conducted to examine interactions between olaparib (a potent oral inhibitor of poly[ADP-ribose] polymerase) and drug transporters"><entity charOffset="69-77" id="DDI-PubMed.27684210.s3.e0" text="olaparib" /></sentence><sentence text=" 2" /><sentence text=" Olaparib showed inhibition of the hepatic drug uptake transporters OATP1B1 (IC50 values of 20" /><sentence text="3 μM and 27" /><sentence text="1 μM) and OCT1 (IC50 37" /><sentence text="9 μM), but limited inhibition of OATP1B3 (25% at 100 μM); inhibition of the renal uptake transporters OCT2 (IC50 19" /><sentence text="9 μM) and OAT3 (IC50 18" /><sentence text="4 μM), but limited inhibition of OAT1 (13" /><sentence text="5% at 100 μM); inhibition of the renal efflux transporters MATE1 and MATE2K (IC50s 5" /><sentence text="50 μM and 47" /><sentence text="1 μM, respectively); inhibition of the efflux transporter MDR1 (IC50 76" /><sentence text="0 μM), but limited inhibition of BCRP (47% at 100 μM) and no inhibition of MRP2" /><sentence text=" At clinically relevant exposures, olaparib has the potential to cause pharmacokinetic interactions via inhibition of OCT1, OCT2, OATP1B1, OAT3, MATE1 and MATE2K in the liver and kidney, as well as MDR1 in the liver and GI tract"><entity charOffset="35-43" id="DDI-PubMed.27684210.s15.e0" text="olaparib" /></sentence><sentence text=" Olaparib was found to be a substrate of MDR1 but not of several other transporters"><entity charOffset="1-9" id="DDI-PubMed.27684210.s16.e0" text="Olaparib" /></sentence><sentence text=" 3" /><sentence text=" Our assessments indicate that olaparib is a substrate of MDR1 and may cause clinically meaningful inhibition of MDR1, OCT1, OCT2, OATP1B1, OAT3, MATE1 and MATE2K"><entity charOffset="31-39" id="DDI-PubMed.27684210.s18.e0" text="olaparib" /></sentence><sentence text="" /></document>